Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 5/20 | 0.41 |
| ▸ | CTNNB1 | P35222 | 5/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 8/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 7/20 | 0.40 |
| ▸ | KCNQ4 | P56696 | 1/20 | 0.39 |
| ▸ | KCNQ5 | Q9NR82 | 1/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | AAK1 | Q2M2I8 | 3/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7145949 | 0.92 | HDAC2 (0.40) | BCL9CTNNB1HDAC2HDAC1KCNQ4 | |
| SCHEMBL7143512 | 0.87 | AAK1 (0.45) | HDAC2HDAC1KCNQ4KCNQ5GRM2 | |
| SCHEMBL7141294 | 0.87 | HDAC2 (0.41) | HDAC2HDAC1KCNQ4KCNQ5GRM2 | |
| SCHEMBL7145392 | 0.85 | HDAC2 (0.44) | HDAC2HDAC1KCNQ4KCNQ5GRM2 | |
| SCHEMBL7142729 | 0.85 | KCNQ4 (0.40) | HDAC2HDAC1KCNQ4KCNQ5GRM2 | |
| SCHEMBL7144215 | 0.85 | KDM4E (0.44) | HDAC1KDM4EHTTKMT2AAAK1 | |
| SCHEMBL7146551 | 0.84 | ABCB1 (0.39) | BCL9CTNNB1KCNQ4KCNQ5KDM4E | |
| SCHEMBL3766409 | 0.81 | HDAC2 (0.51) | HDAC2HDAC1KCNQ4KCNQ5GRM2 | |
| SCHEMBL7141564 | 0.80 | HDAC2 (0.45) | HDAC2HDAC1KCNQ4KCNQ5GRM2 | |
| SCHEMBL5558290 | 0.80 | KDM4E (0.43) | KDM4EHTTKMT2AAAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1224174-B1 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2003-09-17 | — | — | EP | disclosed |
| EP-1224174-A2 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-07-24 | — | — | EP | disclosed |
| US-6407094-B1 | 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA | HOFFMANN-LA ROCHE INC. | 2002-06-18 | — | — | US | disclosed |
| WO-2001029011-A2 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-04-26 | — | — | WO | disclosed |